Your session is about to expire
← Back to Search
High SES/High Supports for Beliefs About Child Development (FSBS Trial)
N/A
Waitlist Available
Led By Dana Suskind, M.D.
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must live in the United States
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at enrollment only
Awards & highlights
FSBS Trial Summary
This study is evaluating whether the type of scenario presented to participants before taking a survey affects how they answer subsequent questions.
FSBS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowFSBS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at enrollment only
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at enrollment only
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Beliefs about the role of parenting and family supports on child development
Secondary outcome measures
Stress and self-efficacy
FSBS Trial Design
4Treatment groups
Experimental Treatment
Group I: Low SES/Low SupportsExperimental Treatment1 Intervention
Participants assigned to the "Low SES/Low Supports" arm will see the "Low SES/Low Supports" intervention
Group II: Low SES/High SupportsExperimental Treatment1 Intervention
Participants assigned to the "Low SES/High Supports" arm will see the "Low SES/High Supports" intervention
Group III: High SES/Low SupportsExperimental Treatment1 Intervention
Participants assigned to the "Low SES/High Supports" arm will see the "High SES/Low Supports" intervention
Group IV: High SES/High SupportsExperimental Treatment1 Intervention
Participants assigned to the "High SES/High Supports" arm will see the "High SES/High Supports" intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
High SES/Low Supports
2021
N/A
~210
Low SES/High Supports
2021
N/A
~210
Low SES/ Low Supports
2021
N/A
~210
High SES/High Supports
2021
N/A
~210
Find a Location
Who is running the clinical trial?
University of ChicagoLead Sponsor
997 Previous Clinical Trials
817,493 Total Patients Enrolled
Dana Suskind, M.D.Principal InvestigatorUniversity of Chicago
1 Previous Clinical Trials
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger